Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Summary for Mega-Scandal

Mega-Scandal: Drug Pricing Abuses
Description: This list shows cases in which drug companies paid penalties of $25 million or more in cases related to improper reporting of wholesale prices and the failure to offer government agencies the same rebates given to private-sector customers.
Penalty Total since 2000$8,669,833,464
Number of Penalty Records: 80
Note: The totals here are adjusted to account for the fact that each current parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Pfizer$1,028,100,3487
Viatris$1,023,000,0009
McKesson$810,000,0005
Teva Pharmaceutical Industries$801,252,5478
Merck$764,000,0007
Sandoz Group$560,110,6184
Indivior PLC$487,500,0002
GlaxoSmithKline$419,653,9315
Centene$415,517,6524
Sun Pharmaceuticals$280,843,0002

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent ParentCurrent Parent IndustryPrimary Offense TypeYearAgencyPenalty Amount sort icon
Pfizer Inc.PfizerpharmaceuticalsFalse Claims Act and related2016DOJ_CIVIL$784,600,000
Merck & CompanyMerckpharmaceuticalsFalse Claims Act and related2008DOJ_CIVIL$650,000,000
Mylan Inc.ViatrispharmaceuticalsFalse Claims Act and related2017DOJ_CIVIL$465,000,000
Mylan Inc.ViatrispharmaceuticalsFalse Claims Act and related2017MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $465,000,000
Indivior Inc.Indivior PLCpharmaceuticalsprice-fixing or anti-competitive practices2024private lawsuit-federal$385,000,000
Wyeth Pharmaceuticals, Inc.PfizerpharmaceuticalsFalse Claims Act and related2016MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $371,351,180
McKesson Corp.McKessonwholesalersprice-fixing or anti-competitive practices2009private lawsuit-federal$350,000,000
Schering-Plough CorporationMerckpharmaceuticalskickbacks and bribery2004MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $292,969,482
MerckMerckpharmaceuticalsFalse Claims Act and related2008MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $290,000,000
Dey Inc.ViatrispharmaceuticalsFalse Claims Act and related2010DOJ_CIVIL$280,000,000
Roxane Laboratories Inc.Hikma PharmaceuticalspharmaceuticalsFalse Claims Act and related2010DOJ_CIVIL$280,000,000
Teva Pharmaceuticals USA, Inc.Teva Pharmaceutical Industriespharmaceuticalsprice-fixing or anti-competitive practices2023DOJ_ANTITRUST$275,000,000
Mallinckrodt ARD LLCMallinckrodtpharmaceuticalsFalse Claims Act and related2022DOJ_CIVIL$260,000,000
Bayer CorporationBayerchemicalsFalse Claims Act and related2003DOJ_CIVIL$251,000,000
Centene CorporationCentenehealthcare servicesFalse Claims Act and related2023CA-AG$215,000,000
Taro Pharmaceuticals USA, Inc.Sun PharmaceuticalspharmaceuticalsFalse Claims Act and related2021DOJ_CIVIL$213,200,000
Sandoz Inc.Sandoz Grouppharmaceuticalsprice-fixing or anti-competitive practices2020DOJ_ANTITRUST$195,000,000
McKesson CorporationMcKessonwholesalersFalse Claims Act and related2012DOJ_CIVIL$190,000,000
Bristol-Myers SquibbBristol-Myers SquibbpharmaceuticalsFalse Claims Act and related2008MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $187,000,000
Sandoz Inc.Sandoz GrouppharmaceuticalsFalse Claims Act and related2021DOJ_CIVIL$185,000,000
Teva Pharmaceuticals Inc.Teva Pharmaceutical IndustriespharmaceuticalsFalse Claims Act and related2010MULTI-AG$169,000,000
Par Pharmaceuticals, Inc.Endo InternationalpharmaceuticalsFalse Claims Act and related2011MULTI-AG$154,000,000
McKesson CorporationMcKessonwholesalersFalse Claims Act and related2012MULTI-AG$151,000,000
GlaxoSmithKlineGlaxoSmithKlinepharmaceuticalsFalse Claims Act and related2005DOJ_CIVIL$150,000,000
Sandoz Inc.Sandoz Grouppharmaceuticalsprice-fixing or anti-competitive practices2011private lawsuit-federal$150,000,000
TAP Pharmaceutical ProductsTakeda Pharmaceuticalpharmaceuticalsprice-fixing or anti-competitive practices2005private lawsuit-federal$150,000,000
Abbott Laboratories Inc.AbbViepharmaceuticalsFalse Claims Act and related2010DOJ_CIVIL$126,500,000
King PharmaceuticalsPfizerpharmaceuticalsFalse Claims Act and related2005DOJ_CIVIL$124,000,000
King PharmaceuticalsPfizerpharmaceuticalsFalse Claims Act and related2006MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $124,000,000
Actavis Mid-Atlantic LLCTeva Pharmaceutical Industriespharmaceuticalsprice-fixing or anti-competitive practices2011private lawsuit-federal$118,614,000
Mylan Pharmaceuticals and UDL LaboratoriesViatrispharmaceuticalsFalse Claims Act and related2009DOJ_CIVIL$118,000,000
Mylan Pharmaceuticals, Inc.ViatrispharmaceuticalsFalse Claims Act and related2009MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,000,000
Bayer AGBayerchemicalsFalse Claims Act and related2003MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000
Mylan Laboratories et al.Viatrispharmaceuticalsprice-fixing or anti-competitive practices2000MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000
Indivior Inc.Indivior PLCpharmaceuticalsprice-fixing or anti-competitive practices2023MULTI-AG$102,500,000
Aventis Pharmaceutical Inc.SanofipharmaceuticalsFalse Claims Act and related2009DOJ_CIVIL$95,500,000
AstraZeneca Pharmaceuticals LPAstraZenecapharmaceuticalsprice-fixing or anti-competitive practices2011private lawsuit-federal$90,000,000
Centene Corp.Centenehealthcare servicesFalse Claims Act and related2021OH-AG$88,300,000
McKesson Corp.McKessonwholesalersprice-fixing or anti-competitive practices2012private lawsuit-federal$82,000,000
Watson Pharmaceuticals, Inc.Teva Pharmaceutical Industriespharmaceuticalsprice-fixing or anti-competitive practices2012private lawsuit-federal$79,000,000
Bristol-Myers SquibbBristol-Myers SquibbpharmaceuticalsFalse Claims Act and related2021USAO$75,000,000
Bristol Myers Squibb Co.Bristol-Myers SquibbpharmaceuticalsFalse Claims Act and related2021MULTI-AG$75,000,000
GlaxoSmithKlineGlaxoSmithKlinepharmaceuticalsprice-fixing or anti-competitive practices2005private lawsuit-federal$75,000,000
GlaxoSmithKlineGlaxoSmithKlinepharmaceuticalsprice-fixing or anti-competitive practices2006MULTI-AG$70,000,000
Watson PharmaceuticalsTeva Pharmaceutical IndustriespharmaceuticalsFalse Claims Act and related2011MULTI-AG$70,000,000
GlaxoSmithKline PLCGlaxoSmithKlinepharmaceuticalsprice-fixing or anti-competitive practices2007private lawsuit-federal$70,000,000
Taro Pharmaceutical USA Inc.Sun Pharmaceuticalspharmaceuticalsprice-fixing or anti-competitive practices2023private lawsuit-federal$67,643,000
Mylan Inc.Viatrispharmaceuticalsprice-fixing or anti-competitive practices2011private lawsuit-federal$65,000,000
Lupin Pharmaceuticals, Inc.Lupin LimitedpharmaceuticalsFalse Claims Act and related2019TX-AG$63,000,000
Johnson & Johnson Vision Care, Inc.Johnson & Johnsonpharmaceuticalsprice-fixing or anti-competitive practices2001MULTI-AG$60,000,000
Mylan Inc.Viatrispharmaceuticalsprice-fixing or anti-competitive practices2012private lawsuit-federal$57,000,000
Centene Corp.Centenehealthcare servicesFalse Claims Act and related2021IL-AG$56,717,652
Centene Corp.Centenehealthcare servicesFalse Claims Act and related2021MS-AG$55,500,000
Schering-Plough CorporationMerckpharmaceuticalsprice-fixing or anti-competitive practices2009private lawsuit-federal$55,000,000
GlaxoSmithKline LLCGlaxoSmithKlinepharmaceuticalsFalse Claims Act and related2019IL-AG$54,653,931
Bristol-Myers SquibbBristol-Myers Squibbpharmaceuticalsprice-fixing or anti-competitive practices2004private lawsuit-federal$50,000,000
Johnson & JohnsonJohnson & JohnsonpharmaceuticalsFalse Claims Act and related2019IL-AG$49,505,368
Omnicare Inc.CVS HealthretailingFalse Claims Act and related2006USAO$49,500,000
Pfizer CorporationPfizerpharmaceuticalsFalse Claims Act and related2002DOJ_CIVIL$49,000,000
Apotex CorporationApotex Corp.pharmaceuticalsFalse Claims Act and related2021DOJ_CIVIL$49,000,000
AstraZeneca LPAstraZenecapharmaceuticalsFalse Claims Act and related2015DOJ_CIVIL$46,500,000
AstraZeneca LPAstraZenecapharmaceuticalsFalse Claims Act and related2015MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000
Pfizer Inc.PfizerpharmaceuticalsFalse Claims Act and related2019IL-AG$41,047,101
Aventis Pharmaceutical Inc.SanofipharmaceuticalsFalse Claims Act and related2009MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000
Vyera Pharmaceuticals, LLC and Phoenixus AG price-fixing or anti-competitive practices2021MULTI-AG$40,000,000
McKesson CorporationMcKessonwholesalersFalse Claims Act and related2013VA-AG$37,000,000
Watson, Inc.Teva Pharmaceutical IndustriespharmaceuticalsFalse Claims Act and related2018MS-AG$33,408,547
Schering-PloughMerckpharmaceuticalsFalse Claims Act and related2008MO-AG$31,000,000
Sandoz, Inc.Sandoz GrouppharmaceuticalsFalse Claims Act and related2011MS-AG$30,110,618
Mylan N.V.Viatrispharmaceuticalsinvestor protection violation2019SEC$30,000,000
Glenmark Pharmaceuticals Inc., USAGlenmark Pharmaceuticalspharmaceuticalsprice-fixing or anti-competitive practices2023DOJ_ANTITRUST$30,000,000
Baxter Healthcare Corp.Baxter Internationalmedical equipment and suppliesprice-fixing or anti-competitive practices2011private lawsuit-federal$29,750,000
Pharmacia CorporationPfizerpharmaceuticalsFalse Claims Act and related2013WI-AG$29,453,247
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLCTeva Pharmaceutical IndustriespharmaceuticalsFalse Claims Act and related2011TX-AG$29,230,000
Abbott Laboratories Inc.AbbViepharmaceuticalsFalse Claims Act and related2008TX-AG$28,000,000
Merck Sharp & Dohme CorpMerckpharmaceuticalsFalse Claims Act and related2010HI-AG$28,000,000
Bristol-Myers SquibbBristol-Myers SquibbpharmaceuticalsFalse Claims Act and related2010PA-AG$27,600,000
Schering-Plough Corp.MerckpharmaceuticalsFalse Claims Act and related2004TX-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $27,000,000
Watson Pharmaceuticals, Inc.Teva Pharmaceutical Industriespharmaceuticalsprice-fixing or anti-competitive practices2011private lawsuit-federal$27,000,000
TAP Pharmaceutical Products, Inc.Takeda PharmaceuticalpharmaceuticalsFalse Claims Act and related2001MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.